Changes in the Rate of Human Papilloma Virus Serotypes after Vaccine Implementation: A Descriptive Study

A. Gallardo, Montserrat de la Torre Serrano, Lone Nielsen, Alejandro Pascual Martín, Concepción Millana de Ynes, María Jesús González Fuensalida, Patricia Barreiro Sanabria, Eva Rodríguez Escudero, D. López, Aranzazu Gómez Rodríguez, Rosa Rodero Villanueva, M. J. Aceñero
{"title":"Changes in the Rate of Human Papilloma Virus Serotypes after Vaccine Implementation: A Descriptive Study","authors":"A. Gallardo, Montserrat de la Torre Serrano, Lone Nielsen, Alejandro Pascual Martín, Concepción Millana de Ynes, María Jesús González Fuensalida, Patricia Barreiro Sanabria, Eva Rodríguez Escudero, D. López, Aranzazu Gómez Rodríguez, Rosa Rodero Villanueva, M. J. Aceñero","doi":"10.4236/ojog.2023.135080","DOIUrl":null,"url":null,"abstract":"Background: The main objective of this study is to describe the rate of the different serotypes of HPV in cervical cytologies and biopsies in three different periods: 2002-2006 (prior to the implementation of the vaccination programs in Spain), 2009-2011 (shortly after this implementation) and 2020 (al-most 15 years after introduction of the vaccine) at a single hospital. Methods: This is an observational, descriptive, retrospective study based on the review of the results of the determination of the HPV serotype using the commercial kit (Genomica ® ; PharmaMar LTD) in cervical liquid-based cytologies and biopsies at a single large tertiary hospital, Hospital Clínico San Carlos, in Madrid, Spain. We have collected the data from three different time periods: 2002-2006; 2009-2011, and 2020 to try to understand the potential changes associated with","PeriodicalId":67381,"journal":{"name":"妇产科期刊(英文)","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"妇产科期刊(英文)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4236/ojog.2023.135080","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The main objective of this study is to describe the rate of the different serotypes of HPV in cervical cytologies and biopsies in three different periods: 2002-2006 (prior to the implementation of the vaccination programs in Spain), 2009-2011 (shortly after this implementation) and 2020 (al-most 15 years after introduction of the vaccine) at a single hospital. Methods: This is an observational, descriptive, retrospective study based on the review of the results of the determination of the HPV serotype using the commercial kit (Genomica ® ; PharmaMar LTD) in cervical liquid-based cytologies and biopsies at a single large tertiary hospital, Hospital Clínico San Carlos, in Madrid, Spain. We have collected the data from three different time periods: 2002-2006; 2009-2011, and 2020 to try to understand the potential changes associated with
接种疫苗后人乳头瘤病毒血清型率的变化:一项描述性研究
背景:本研究的主要目的是描述在三个不同时期:2002-2006年(西班牙实施疫苗接种计划之前),2009-2011年(实施后不久)和2020年(引入疫苗后最多15年)在一家医院的宫颈细胞学和活检中不同血清型HPV的比率。方法:这是一项观察性、描述性、回顾性研究,基于对使用商业试剂盒(Genomica®;在西班牙马德里的一家大型三级医院Clínico圣卡洛斯医院进行宫颈液体细胞学检查和活组织检查。我们收集了三个不同时期的数据:2002年至2006年;2009-2011年和2020年试图了解与之相关的潜在变化
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
1180
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信